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Abstract 
Despite neuroblastoma being the most common extracranial solid malignancy in 
children, it presents a significantly atypical challenge to clinicians and researchers due 
to its complex biological interplay and heterogeneous behaviour. Hypoxia, which is a 
lack of oxygenation, has been implicated as a significant factor leading to metastasis, 
treatment resistance and poor prognosis in many cancers, including neuroblastoma. 
Whilst our lab has previously demonstrated that hypoxic pre-conditioning of 
neuroblastoma cells directly triggers neuroblastoma tumour metastasis, it is not 
known how such preconditioning affects the tumour’s oxygenation itself and how it 
alters the tumour’s metabolism. 
We initially measured intratumoural oxygenation, using a fibre-optic oxygen sensor, in 
tumours originating from neuroblastoma cells and growing on the chorioallantoic 
membrane (CAM) of a chick embryo model. We investigated the effects of hypoxia 
preconditioning of the cells on the actual oxygen levels within the tumour. We further 
investigated, using Nuclear Magnetic Resonance (NMR), the effects of hypoxic 
preconditioning on the metabolic profile of neuroblastoma tumours. 
We demonstrated that hypoxic preconditioning had only a minor effect on 
intratumoural oxygenation values, yet it had a significant measurable influence on the 
metabolic profile of the tumours. 
In particular, 13 metabolites showed a consistent response to hypoxia, with 9 being 
decreased and 4 being increased in the hypoxic sets across cells and tumour, thus 
illustrating the lasting effects of hypoxic preconditioning on the tumour metabolome.  
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1. Introduction 
1.1 Neuroblastoma – A Clinical Perspective: 
Neuroblastoma is a paediatric cancer of remarkable heterogeneity that exhibits an equally 
perplexing biological and clinical behaviour ranging from asymptomatic spontaneous 
regression to an aggressive metastatic treatment-resistant disease. It is the most common 
extracranial solid tumour in childhood and is accountable for almost 8% of all paediatric 
malignancies and 11-15% of paediatric oncology fatalities with an overall survival rate at 
around approximately 40% (1-3). Neuroblastoma arises as a consequence of multiple genetic 
and environmental insults during the early stages of neural crest development leading to 
malignant cellular differentiation (4, 5). 
1.1.1 Embryology & Genetics: 
A series of cellular signalling events termed the epithelial-to-mesenchymal transition (EMT) 
leads to migration, specification, and differentiation of cells that subsequently develop the 
basis of embryological formation (4, 6). Cells originating from the ectoderm develop to form 
a significant proportion of what is collectively known as the nervous system that includes the 
brain, spinal cord, sympathetic chain, cardiac and enteric ganglia, autonomic network, in 
addition to the adrenal glands (4, 7-9). A multitude of genetic and epigenetic factors play a 
role during neural crest development and EMT to contribute to the development of 
neuroblastoma (4). However, an individual genetic or epigenetic factor has not been 
implicated as the sole trigger for neuroblastoma development (10). Although not all the 
players have been identified, several have been implicated as oncogenic drivers in 
neuroblastoma. Chromosomal deletions are detected in approximately 50% of 
neuroblastoma cases and are associated with a poor prognosis (11-14). The chromosomal 
deletions most commonly detected in chromosomes 1p, 11q, and 14q in addition to 
chromosome 17q gain and MYCN gene amplification demonstrate the biological interplay 
resulting in the heterogeneity of neuroblastoma presentation and prognosis (4, 10, 15-17). 
The genetic amplification of the MYCN oncogene in approximately 20-25% of neuroblastoma 
cases is considered as a trigger of metastatic potential and a poor prognostic marker (17-20). 
Other alterations associated with cellular development arrest and neuroblastoma 
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tumourigenesis include anaplastic lymphoma kinase (ALK) gene mutations, neurotrophic 
growth factor (NGF) expression, and changes in DNA content (4, 21). 
Evidently, this interplay of multiple factors during the early stages of embryogenesis 
complicates the identification of a primary pathway for the pathogenesis of neuroblastoma 
and demonstrates the spectrum of neuroblastoma heterogeneity.  
1.1.2 Pathology & Staging: 
The unique complexity of neuroblastoma is highlighted by the spectrum of the malignancy 
that ranges from asymptomatic spontaneous regression to a fatal aggressive metastatic 
disease. This heterogeneity is reflected in all aspects of the disease including the staging and 
classification systems, broad range of clinical presentations and behaviour, multimodal 
treatment approaches, selective therapeutic responsiveness, and range of prognostic factors. 
Neuroblastoma lies within a spectrum of neuroblastic tumours classified by the International 
Neuroblastoma Pathology Classification (INPC) based on the proportion of neural derived 
cells and Schwannian stroma cells (22). Ganglioneuroma is the most differentiated subtype 
and is dominant in schwannian stroma followed by ganglioneuroblastoma (22). The least 
differentiated subtype, neuroblastoma, is poor in schwannian stroma and consequently the 
most aggressive neuroblastic tumour (22).  
Conventionally, the International Neuroblastoma Staging System (INSS) has been widely 
adopted since its development in 1986 (23). Tumour staging relies mainly on a post-surgical 
assessment of the tumour as outlined in table 1 below adapted from Brodeur and Pritchard 
et al., 1993 (24).  
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INTERNATIONAL NEUROBLASTOMA STAGING SYSTEM (POST-
SURGICAL STAGING) 
Stage Description 
1 
Localised tumour confined to the area of origin; complete gross excision with 
or without microscopic residual disease; identifiable ipsilateral and 
contralateral lymph nodes microscopically negative. 
2a Unilateral tumour with incomplete gross excision; identifiable ipsilateral and 
contralateral lymph nodes microscopically negative. 
2b 
Unilateral tumour with incomplete gross excision with positive ipsilateral 
regional lymph nodes; identifiable contralateral lymph nodes 
microscopically negative. 
3 
Tumour infiltrating across the midline with or without regional lymph node 
involvement; or unilateral tumour with contralateral regional lymph node 
involvement; or midline tumour with bilateral regional lymph node 
involvement. 
4 Dissemination of tumour to bone, bone marrow, liver, distant lymph nodes, 
and/or other organs except as defined for stage 4S 
4s Localised primary tumour –as defined for stages 1 or 2- with dissemination 
limited to liver, skin, and/or <10% of bone marrow. Age <1 year at diagnosis. 
Table 1.  The International Neuroblastoma Staging System  
This classification system developed in 1986 has been widely accepted and adopted as a staging 
tool for neuroblastoma. This tool stages neuroblastoma from a pre and post-surgical perspective 
and precedes the International Neuroblastoma Risk Group Staging System (INRGSS).                               
         Adapted from Brodeur and Pritchard et al., 1993 (24) 
 
In parallel with ongoing discoveries around the biological complexity of neuroblastoma over 
the past two decades, the necessity to develop a staging system independent of surgical 
intervention became apparent. This culminated in the introduction of the International 
Neuroblastoma Risk Group Staging System (INRGSS) in 2009 (25, 26). The INRGSS staging is 
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dependent on pre-surgical imaging assessment with 2 stages for localised disease (L1 and L2) 
and 2 stages, M and MS, for metastatic disease (Table 2). 
International Neuroblastoma Risk Group Staging System (INRGSS) 
Stage  Definition 
L1 Tumour localised and confined within 1 body compartment; no vital structure involvement. 
L2 Locoregional tumour + 1 or more image defined risk factors (IDRF) 
M Metastatic Disease unless stage MS 
MS Metastatic Disease in children <18 months old. Metastasis confined to skin and/or liver and/or bone marrow. 
Table 2. The International Neuroblastoma Risk Group Staging System 
The INRGSS was developed to implement an imaging based staging system independent of, and prior to, 
surgical intervention.  
Adapted from: Monclair et al. 2009 (25) 
 
Additionally, there are 20 image-defined risk factors (IDRFs) that complement staging in the 
INRGSS and are identified in table 3 below as adapted from Monclair  et al., 2009 (25).  
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Image Defined Risk Factors in Neuroblastoma 
Region: Tumour: 
Ipsilateral Tumour within 
2 Body Compartments 
Neck-chest, chest-abdomen, abdomen-pelvis 
Neck 
Encasing carotid and/or vertebral artery and/or internal 
jugular vein, Extending to base of skull 
Compressing the trachea 
Cervicothoracic Junction 
Encasing brachial plexus roots, and/or subclavian vessels, 
and/or vertebral/carotid artery 
Compressing the trachea 
Thorax 
Encasing aorta and/or major branches 
Compressing the trachea and/or principal bronchi, Lower 
mediastinal tumour, infiltrates the costo-vertebral 
junction between T9 and T12. 
Thoraco-Abdominal Encasing the aorta and/or vena cava  
Abdomen/Pelvis 
Infiltrating the porta hepatis and/or the hepatoduodenal 
ligament 
Encasing branches of the superior mesenteric artery at 
the mesenteric root, Encasing the origin of the coeliac 
axis, and/or of the superior mesenteric artery 
Invading one or both renal pedicles 
Encasing the aorta and/or vena cava, Encasing the iliac 
vessels 
Pelvic tumour crossing the sciatic notch 
Organ and Structure 
Infiltration 
Pericardium, diaphragm, kidney, liver, duodeno-
pancreatic block and mesentery 
Table 3. The Image Defined Risk Factors in Neuroblastoma  
The INRGSS identifies 20 image-defined risk factors (IDRF) to complement the staging system of 
neuroblastoma.                                                                                                    Adapted from: Monclair et al. 2009 (25) 
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1.1.3 Screening, Presentation, and Diagnosis: 
1.1.3.1 Regression 
Spontaneous tumour regression is an intriguing feature of neuroblastoma. Although not 
exclusive to neuroblastoma, spontaneous regression in neuroblastoma is the most common 
across malignancies such as renal, malignant melanoma, choriocarcinoma, and lymphoid 
carcinoma (27-30). This enigmatic tendency illustrates the spectra of heterogeneity in 
neuroblastoma from spontaneous regression to therapeutic resistance and mortality. Current 
understanding of the biological and genetic mechanisms responsible for this tendency are 
limited, however, mass screening programmes in Japan, Austria, Germany, and Canada have 
shed light on this intriguing characteristic (31-36).  
1.1.3.2 Screening: 
Mass screening of infants in Japan tested urine for Vanillylmandelic acid (VMA) and 
Homovanillic Acid (HVA) from 1973 until 1989 (32). As a result, there was a noticeable 
increase in neuroblastoma detection with an insignificant decrease in the overall mortality 
rates (31, 32, 35). Cases that would spontaneously regress were almost as equal as cases that 
would have eventually been detected clinically. Consequently, all the neuroblastoma 
screening programmes have been suspended as they have not achieved their intended 
targets of significantly decreasing mortality rates (30, 31). They have, however, contributed 
valuable insight to scientists and clinicians seeking new ways to approach and investigate 
neuroblastoma. 
1.1.3.3 Presentation: 
As neuroblastoma arises from the neural crest precursor cells, the resulting tumour may arise 
from any site of the sympathetic chain, adrenal glands, or the central and autonomous 
nervous systems. Tumours develop in the adrenal glands, abdomen, thoracic cavity, neck, and 
the pelvic sympathetic ganglia. These tumours may metastasise to the liver, skin, lymph 
nodes, bone, bone marrow, dura, eye orbits, and skin (24, 37, 38).  The incidence of metastasis 
at diagnosis in a series of 648 children with stage 4 and 4s neuroblastoma showed 70.5% in 
bone marrow, 55.7% in bone, 30.9% in lymph nodes, 29.6% in liver, 18.2% in head, neck and 
orbits, 3.3% in lungs, and 0.6% in the CNS (37).  
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Presentation can be as variable as the sites of neuroblastoma formation and ranges from 
asymptomatic to systemic illness. Intra-abdominal tumours usually present with distension, 
abdominal pain, and weight loss (39). Tumours arising from the thorax cause mechanical 
obstruction and respiratory compromise and present with dyspnoea, stridor, cough, tracheal 
compression or deviation (39, 40). Horner’s syndrome, a triad of ptosis, mitosis, and 
anhydrosis, is associated with high thoracic tumours in neuroblastoma (39, 40). A paraspinal 
tumour leads to loss of anal sphincter control and urinary incontinence which may require an 
emergency intervention (39). Periorbital bone invasion presents as proptosis, otherwise 
known as raccoon eyes (periorbital ecchymosis) (fig. 1)(41). 
 
 
Figure 1. Periorbital ecchymosis in 
neuroblastoma 
This image depicts periorbital ecchymosis -
raccoon eyes- as a presenting feature of 
neuroblastoma in a 10 month old boy. 
      
  Source: Kapoor, 2014. (41)  
 
1.1.4 Treatment: 
A multimodal approach to treat neuroblastoma encompasses immunotherapy, 
differentiation therapy, chemotherapy, radiotherapy, and surgical intervention (17). This is 
dependent on the stage of the disease and tumour classification and whether the patient is 
determined as a low, intermediate, or high-risk case. 
The majority of neuroblastoma patients present with unresectable or metastatic disease (17). 
Cases of localised tumours with positive biological profiles and localised recurrences may be 
treated surgically (17).  Intermediate-risk cases may require a combination of chemotherapy 
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and surgical resection. Cases complicated by metastasis would require chemotherapy and/or 
radiotherapy (17). High-risk neuroblastoma is treated intensively with a combination of 
chemotherapy, surgery, and radiotherapy (17). CT, MRI, and MIBG scans along with urinary 
catecholamine tests are used to monitor treatment response (17). 
1.2 Neuroblastoma – A Biological Perspective: 
1.2.1 Cancer Cell Metabolism 
Metabolic activity alteration, or deregulation of cellular energetics, was designated as an 
emerging hallmark of cancer by Hanahan and Weinberg (2011) (fig.2A) (42). The original 
discovery of metabolic changes in cancer is accredited to the work of Nobel Laureate Otto 
Warburg in 1924 who hypothesised that cancer is caused by the tendency of cancer cells to 
produce ATP by non-oxidative fermentation regardless of the presence of oxygen (43, 44). To 
elaborate, in the presence of oxygen, normal cells produce energy via the oxidative 
breakdown of pyruvate in Krebs cycle generating 36 molecules of ATP per glucose molecule. 
In the absence of oxygen, normal cells resort to anaerobic respiration and produce energy 
through the less efficient breakdown of pyruvate into lactate and produces 2 ATP molecules 
per glucose molecule. The Warburg Hypothesis states that the tendency of tumour cells to 
produce energy through the latter method of glycolysis, non-oxidative glucose breakdown, 
regardless of the presence of oxygen is the underlying cause of cancer (Warburg, 1924). While 
the Warburg Effect (fig.2B) is the most prominent metabolic alteration in cancer, other 
metabolic changes have been identified (45). The marked increase of pyruvate kinase isoform 
M2, mutations of isocitrate dehydrogenase 1 and 2, and altered glutaminolysis are examples 
of further metabolic observations in cancer (46-48).  
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Figure 2. Metabolic Deregulation in Cancer Cells 
A. Metabolic Deregulation as a Hallmark of Cancer. The Hallmarks of Cancer, as described by Hanahan and Weinberg 
(2011), include the deregulation of cellular energetics as an emerging hallmark. The importance of this feature was 
first described by Otto Warburg in what later became known as aerobic glycolysis, or the Warburg Effect (42, 49) (see 
fig.6). 
 Image credit: Hanahan & Weinberg, 2011 (42) 
B. Illustration depicting cellular energy production in differentiated tissue and tumour cells. This illustration 
depicts the production of cellular energy via glycolysis regardless of the presence or absence of oxygen in 
cancer cells (right). This is known as the Warburg Effect, or aerobic glycolysis. Normal cells (left) produce 
energy via oxidative phosphorylation and resort to anaerobic respiration only in the absence of oxygen. 
Image credit: http://2015.igem.org/wiki/images/b/b2/ETHZ-Warburg.png (as adapted from Heiden V. 2009 (49) ) 
 
1.2.2 Metabolomics 
Metabolomics is the study of the metabolites in a biological system and holds promising 
potential in cancer biology and biomarker discovery (50). Metabolomics provides the closest 
snapshot of the phenotype and function of cells and is a more recent field than the other 
three omics, genomics, transcriptomics, and proteomics and (51). Although the total number 
of human metabolites is not yet known, it is estimated to be in the tens of thousands (52, 53). 
The sensitivity of metabolomics and relatively low per-sample cost allow for testing a large 
number of samples and generating sizeable amounts of data. These factors, combined with 
technological advances, have kindled the interest of cancer researchers in the search for 
diagnostic biomarkers in serum, urine, and less commonly solid tissue samples. The value of 
A B 
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metabolomics in the search for cancer biomarkers is highlighted by the multitude of literature 
encompassing more than 15 types of cancer (54).  
Nuclear Magnetic Resonance (NMR) and Mass Spectrometry are two technical approaches in 
metabolomics and this study used the former approach. NMR provides higher reproducibility 
than mass spectrometry, albeit with less sensitivity and specificity (55). Additionally, samples 
require less preparation and are preserved for future analysis with NMR as opposed to mass 
spectrometry in which samples require more complex preparation and are destroyed (56). 
NMR is capable of detecting 40-200 metabolites and mass spectrometry could potentially 
detect more than 500 (56). High reproducibility, ease of sample preparation, short 
experiment duration, sample preservation, and low per-sample cost constitute the 
advantages of NMR spectroscopy in metabolomics. Although tumour tissue is more 
challenging to obtain and prepare than common bio-fluid samples such as serum and urine, 
research interest in direct tumour metabolomics has been increasing (52). A cancer biomarker 
could be measured as part of diagnostic testing, to assess tumour staging and aggressiveness, 
metastasis potential, and response to therapy (57). 
Specifically, the metabolomics of neuroblastoma biopsy samples have been analysed to 
associate metabolites with patient age, prognosis, active disease, and remission (58). 
1.2.3 Hypoxia  
Hypoxia, or oxygen deprivation, is a characteristic feature of solid tumours defined as “a state 
in which the level of oxygen is decreased relative to the normal level” (59).  This state of 
hypoxia in solid tumours is associated with an increased metastatic potential, reinforced 
therapeutic resistance, decreased tumour apoptosis, cancer progression, treatment 
resistance, and an overall poor clinical outcome (60-65). 
Under hypoxic stress, the Hypoxic-Inducible Factor (HIF) transcription factor is activated 
triggering gene up-regulation and cellular responses to promote cell survival (66). This cellular 
response to hypoxia involves alteration of gene expression via the stabilisation and activation 
of the Hypoxia Inducible Factor (HIF) (66). In turn, this promotes cell survival by ensuring 
increased oxygen delivery (erythrocyte production, angiogenesis stimulation) and reduced 
oxygen consumption (increased glycolysis) (67-71). Erythropoietin (EPO) hormone levels 
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increase to produce red blood cells and ultimately raise the oxygen carrying capacity of blood 
(67). Angiogenesis, the formation of new blood vessels, is stimulated by the release of 
vascular endothelial growth factor (VEGF) in hypoxia (68). Anti-apoptosis, tumour 
proliferation, metastatic potential, increased glycolysis, pH alteration, and iron imbalance are 
other identified cellular responses to HIF expression and hypoxia (69-76). 
1.2.3.1 Causes: 
Hypoxia results from a low oxygen supply and poor distribution due to weak tumour 
vasculature increased diffusion distances, and rapid tumour proliferation (77, 78). Dewhirst 
et al (2008) explains the multifactorial interplay resulting in tumour hypoxia (fig.3) (79). 
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As a consequence of tumour growth, vasculature development, changes in diffusion 
distances, and unstable oxygen transportation, tumours exhibit cycling, rather than static, 
Figure 3. The 7 characteristics regulating tumour oxygenation as described by Dewhirst 
et al. (2008). 
The intravascular drop of the partial pressure of oxygen in distal arterioles accompanied with 
diversion of blood flow from shunts, and restricted oxygen diffusion to the tumour along with 
uncoordinated blood vessel arrangements, increased oxygen demands from the growing tumour, 
and decreased blood flow rates due to the hypoxic effect of increasing blood viscosity all combine 
to result in the characteristic feature of tumour hypoxia. 
Image Credit: Dewhirst et al, 2008 (79)  
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hypoxia (79, 80). The tumour microenvironment is dynamically hypoxic in that oxygen levels 
fluctuate in acute and chronic cycles (79). Whilst tumour hypoxia has been extensively 
reported as a poor prognostic marker in disease, much remains to be discovered with regards 
to the intracellular modifications associated with hypoxia and their link with the metastatic 
phenotype (81, 82).   
1.2.3.2 Hypoxia and Neuroblastoma:  
Hypoxia in neuroblastoma translates these biological alterations into the clinical setting and 
leads to chemoresistance of etoposide and vincristine, both commonly adopted 
chemotherapy agents (83). Moreover, recent work by Herrmann et al. (2015) utilising the 
chick embryo chorioallantoic membrane (CAM) model has shown that hypoxic 
preconditioning of in vivo neuroblastoma cells activates the cancer’s metastasis potential and 
the regulation of genes supporting tumour dissemination (84). Additionally, neuroblastoma 
cells preconditioned in hypoxia have shown a truly fascinating phenomenon in that they 
trigger metastasis in adjacent cells not previously preconditioned in hypoxia and thus lack the 
metastatic phenotype (84). Specifically, hypoxia has been identified as an independent poor 
prognostic factor in neuroblastoma (85).    
 
1.2.4 Chick Embryo CAM Model: 
1.2.4.1 Introducing the model: 
In vivo experimentation is a fundamental stage in research that provides more in-depth 
insight and translatable knowledge than in vitro studies as they comprise of a complete 
biological system in contrast to an isolated in vitro model that lacks vital features such as a 
stroma and a vascular system. Various organisms and animal models have been used for 
cancer research such as the murine, avian, and zebrafish models.  
The chick embryo model was first exploited in the early 20th century when Rous and Murphy 
famously implanted Rous 45 chicken sarcoma onto the chorioallantoic membrane of the chick 
embryo (86). This discovery established the suitability of the CAM model for in vivo cancer 
research and tumour cell implantation to this day (87). While the mouse model would either 
require drug-induced immunodeficiency or special husbandry to produce genetically 
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modified immunodeficient mice prior to tumour cell implantation, the chick embryo is 
naturally immunocompetent until embryological day 18 (87).  Additionally, chick embryo 
experimentation up to embryonic day 14 does not require a U.K. Home Office license or 
ethical approval. Additionally, tumour growth on the CAM develops over a course of days as 
opposed to weeks in alternative animal models. Moreover, the chick embryo model is simple 
from a technical perspective and does not accrue high costs. This allows for a rapid, high 
turnover at a low expenditure.  
1.2.4.2 Suitability for Neuroblastoma Research: 
The distinctive feature of the chick embryo model that makes it ideal for solid tumour 
research is the chorioallantoic membrane (CAM). The CAM is an easily accessible, heavily 
vascularised extraembryonic structure that surrounds the developing embryo acting as a 
placenta that acts as an efficient host for tumourigenesis in that most implanted tumours 
complete extravasation within 24 hours, much faster than the murine model (87). 
Additionally, the accessibility to the tumour afforded by the CAM model allows for simple 
tumour cell implantation and subsequent investigations, such as tumour imaging and oxygen 
readings in our case.  
1.2.4.3 Limitations: 
A negative aspect of the chick embryo model is the loss of embryos during the process of 
implantation and incubation due to sensitivity to any alteration in temperature, humidity, pH, 
and oxygen tension (87). Moreover, chick embryos are prone to infection secondary to the 
opening of the shell during tumour cell implantation, which could be reduced by following 
standard aseptic techniques. 
1.2.5 SK-N-AS Cells: 
The neuroblastoma cell line utilised throughout this project is derived from a metastatic bone 
marrow site of a 6 year old Caucasian female diagnosed with poorly differentiated 
neuroblastoma in 1981 (88). Biologically, SK-N-AS cells are non-MYCN amplified 
neuroblastoma cells.  Previous work in our laboratory by Herrmann et al. (2015) has 
succeeded in optimising the culture of SK-N-AS cells on the chick embryo model under hypoxic 
conditions (84). These cells have shown metastatic potential when pre-conditioned under 
The Effects of Hypoxic Preconditioning on the Oxygenation and Metabolic Profile of 
Neuroblastoma – Yousef Al-Mutawa 
 
20 
 
hypoxic conditions prior to implanting upon the chick embryo. In continuity with these 
findings and to limit confounding variables, the same SK-N-AS cell line has been utilised in this 
project.  
1.3 Hypothesis: 
Previous work by Herrmann et al. (2015) has found that a short incubation time (72 hrs) of 
neuroblastoma cells in 1% O2 resulted in a drastic phenotypic alteration of the neuroblastoma 
cells leading to cellular metastasis of the incubated cells suggesting a form of cellular memory 
of previous exposure to hypoxia (84).  It is our hypothesis that hypoxic incubation causes 
lasting modifications in the cellular metabolome responsible for the phenotypic changes and 
activation of the metastatic potential in these cells.  
1.4 Project Aim: 
The specific targets of this study were as follows: 
1. To record live oxygen readings of in vivo neuroblastoma tumours implanted on the 
chorioallantoic membrane of chick embryos. 
2. Analyse the metabolic profile of neuroblastoma tumours, using nuclear magnetic 
resonance spectroscopy (NMR). 
3. To compare and contrast the effects of hypoxic preconditioning of the neuroblastoma 
cells on the oxygenation and metabolic profiles of the neuroblastoma tumours. 
 
2. Methods: 
In this experiment, neuroblastoma cells (SK-N-AS) are implanted onto the chorioallantoic 
membrane and develop into a neuroblastoma tumour within 7 days (embryonic day 14). 
Tumours are then imaged and either undergo live oxygen measurements or harvested for 
metabolic profiling via nuclear magnetic resonance spectroscopy (NMR). 
Cell culture reagents were purchased from Gibco (USA) and plasticware from Corning (USA) 
unless otherwise stated. All other chemicals and reagents were obtained from Sigma-Aldrich 
(USA) unless otherwise stated. 
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2.1 Egg incubation: 
The required number of embryonated White Leghorn chicken eggs per experiment was 
removed from the refrigerator (12°C) and the eggs were cleaned with a damp blue towel to 
remove any impurities or debris from the shell. The eggs were labelled on the long side with 
the date and initials to act as identifiers. They were then placed into a table-top egg incubator 
(Brinsea, U.K.) to lie horizontally with the labelling facing upwards (fig.4). The eggs remained 
in a humidified incubator for 72 h at 37°C without movement or rolling, to ensure embryo 
formation in the appropriate orientation. In this setup, the embryo forms beneath the 
labelling allowing this to be the windowing site. This incubation step marks embryonic day 0, 
E0 (fig.4). 
2.2 Windowing: 
On Embryonic day 3, the eggs were windowed in preparation for cell implantation onto the 
chorioallantoic membrane on Embryonic Day 7 (E7). The fume hood was prepared along with 
the following tools: scalpel, egg piercer, syringe, and drill. Egg trays and dividers are prepared 
and remain in a secondary egg incubator for the duration of windowing. The eggs were 
 
  
Figure 4. Embryonic Day 0 
A. After being cleaned and labelled for subsequent windowing, the eggs are placed horizontally 
in a Brinsea table-top egg incubator to allow CAM development. 
B. Top view of the incubator: The eggs remain undisturbed in this position.  
A B 
The Effects of Hypoxic Preconditioning on the Oxygenation and Metabolic Profile of 
Neuroblastoma – Yousef Al-Mutawa 
 
22 
 
removed from the incubator and rolled gently by hand to detach the contents from the shell. 
The eggs were wiped with water and placed on the egg holder in the fume hood with the 
labelling facing upwards. The wide base of the eggs was pierced with an egg piercer to 
withdraw approximately 3 ml. of albumin withdrawn via a needle and syringe after which the 
piercing was covered with green tape (fig.5 A-B). The needle must be facing the inferior 
surface to avoid disrupting the embryo. This step is followed by drilling a rectangular window 
then using a scalpel to sever three sides of the shell window (fig.5 C-D). Invisible Scotch tape 
was attached onto the window to completely detach it from the shell and replacing it securely 
ensuring there are no air bubbles in the tape that would allow exchange between the inner 
egg and outer environment and cause disturbance to the egg’s gas exchange mechanism. It 
was essential to form an air seal to prevent infections and improve the chance of embryo 
survival for the duration of the experiment (14 days) (fig.5 E). One end of the tape was kept 
loose to permit lifting of the window for implantation. The egg was placed into the tray in the 
incubator and this process was repeated until all eggs have been windowed (fig.5 F). The tray 
was then transferred to the primary egg incubator and disruption was avoided until 
embryonic day 7 for implantation. It was vital to ensure the incubator had a sufficient water 
supply throughout the period of incubation.  
 
 
 
 
 
 
 
 
The Effects of Hypoxic Preconditioning on the Oxygenation and Metabolic Profile of 
Neuroblastoma – Yousef Al-Mutawa 
 
23 
 
  
  
  
Figure 5. Embryonic Day 3 – Windowing 
A. The wide base of the egg is pierced to allow insertion of a syringe needle. 
B. Approximately 3ml of albumin are withdrawn from each egg causing the CAM to descend 
in order to allow drilling without disturbing the egg contents. 
C:  A rectangular window is drilled onto the eggshell above the site where the embryo has 
formed.   
D - E: A scalpel is used to sever three ends of the window which is then sealed by Scotch tape 
to limit gas exchange and minimise the risk of infections and embryo death.  
F: The windowed eggs are arranged in an egg tray with the windowed areas facing upwards 
and placed in an egg incubator.  
 
A B 
C D 
E F 
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2.3 Chorioallantoic implantation (Embryonic day 7):  
Eggs were placed under a fume hood while unfertilised and dead eggs were discarded. SK-N-
AS cells were pelleted in eppendorfs and kept in ice.  The number of cells to be implanted are 
between 2 to 4 million cells and the volume is calculated beforehand (sample calculation in 
table 4). 
Table 4. Calculating the volume of cells to inject into the chorioallantoic membrane 
Cells/ml of medium 869000 ß as read by the cell counter (Biorad) 
Total ml. of media 50 
  
Total number of cells  43450000 
  
Volume of cell pellet (μl) 50 
  
cells/μl 8.69E+05 
By dividing total # of cells by the pellet 
volume 
    
for 2*10^6 cells  2000000 (divide 2*10^6 ) / (cells/μl) 
inject (μl): 2 Volume of cells to inject in μl 
 
 
The equipment needed for cell implantation are an optical microscope, sterile tissue paper, 
tweezers, and a pipette. Under the microscope, the egg window was lifted and tissue paper 
was inserted within the chorioallantoic membrane to create an inward fold that encloses the 
cells. The cells are then pipetted into the fold (fig. 6). The egg window was replaced and taped 
on the shell. This procedure was repeated until all eggs were implanted with the appropriate 
cell number and condition. Care must be taken to minimise egg movement and rotation 
following implantation. 
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Figure 6. Embryonic Day 7 – Cell Implantation.  
On embryonic day 7, SK-N-AS neuroblastoma cells are implanted onto the chorioallantoic 
membrane of the chick embryos. Care must be taken to ensure this step is performed in the shortest 
period required as the chick embryos are sensitive to disruptions in temperature and humidity. 
 
2.4 In-vivo Oxygen Measurement: 
On embryonic day 14, the oxygen tension of tumours was measured followed by tumour 
imaging and harvesting (fig.7). This was carried out with a Presens Microx 4 oxygen sensor 
device, a Needle Type Oxygen Microsensor NTH-PSt7 (Presens), a standard fluorescent stereo 
microscope (Leica M165FC), and a Manual Micromanipulator MM33 (Presens) (fig.8). With 
care to avoid breaking the egg, the shell on the side of the window was removed using 
tweezers to reveal the entire contents of the egg. If a tumour was present, an image of the 
CAM was taken in bright light and another in fluorescence (fig.7). The needle microsensor was 
fitted into the micromanipulator and connected to the Microx device and the temperature 
probe was inserted into the membrane of a control egg. Next, the needle was forwarded into 
the tumour and retracted slightly to allow the fibre optic sensor to be in direct contact with 
the tumour microenvironment (fig.8). Measurement times ranged from 15 to 40 minutes. The 
needle was retracted carefully from the tumour upon completion. 
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A 
    
B 
 
Figure 7. Display of tumour imaging and oxygen reading. 
A. Tumour Images. This figure displays images of a single neuroblastoma tumour on the CAM and 
after dissection. The neuroblastoma SK-N-AS cells used are GFP-labelled and appear in green in GFP 
view. Image Description from left: CAM Bright Field, CAM – GFP view, Dissected Bright field, 
Dissected – GFP. 
B. Tumour Oxygen recording. Visual representations of a tumour oxygen reading recorded by a 
fibre-optic oxygen microsensor in a neuroblastoma tumour on the CAM of a chick embryo. 
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A 
 
B 
 
Figure 8. Embryonic Day 14 – Oxygen readings 
Embryonic day 14 is the final day of the chick embryo experimentation.  
A. The shell is cracked to reveal the underlying tumour and chick embryo. Under microscopic 
guidance, the fibre-optic needle is inserted into the tumour to detect and record live intra-tumoural 
oxygen readings.  
B.  The Presens Oxygen Microsensor displays and records the live intratumoural oxygen tension at 
2 second intervals. 
 
2.5 Tumour Extraction: 
A small dissection scissor and tweezer were used to dissect the tumours from the membranes 
and are placed on drops of phosphate buffered saline to remove any blood after which the 
chick embryos were sacrificed at this point. Imaging of the tumours in bright light and 
fluorescence were taken in a posterior and side orientation. The method of storing tumours 
is dependent on the subsequent step. Both methods are explained below. 
2.5.1 Tumour snap freezing (for NMR): 
The tumour was weighed in an eppendorf and dropped in liquid nitrogen to freeze. The 
tumours are then stored in a -80*C freezer. 
2.5.2 Tumours fixation and staining (for immunostaining): 
Each tumour was placed in a well with 4% paraformaldehyde (PFA, Sigma) in a well plate and 
stored in a refrigerator for 24 hours (fig.9). The PFA was aspirated and the tumour was 
suspended in a sucrose gradient of 6%, 12%, and 20%, respectively. The sucrose would be 
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changed every 24 hours. The tumour was then placed in a plastic embedding mould in 
anterior orientation (as if on the cam) and Cryomatrix (Thermo Scientific, USA) embedding 
solution is added. A cork top is added as a cover and the mould was placed in dry ice to freeze 
and subsequently stored in a -80°C freezer. 
A 
 
B 
 
Figure 9. Tumour extraction and storage:   
A.  Upon extraction, each tumour is suspended in a well with 4% paraformaldehyde (PFA) and 
stored in a refrigerator for 24 hours. The PFA is then replaced with a sucrose gradient of 6%, 12%, 
and 20% respectively.  
B.  Tumours are then placed in a plastic mould and Cryomatrix embedding solution is added. A cork 
top is placed on the matrix and the moulds are placed in liquid nitrogen followed by storage in a -
80*C freezer.  
 
2.6 Tumour Slicing for Imaging: 
The frozen tumours are removed from -80°C storage and kept on dry ice. A Leica CM1950 
cryostat is set to slice 10µm with a temperature of -20*C. A frozen tumour mould is removed 
from the mould and frozen into place onto the metal specimen discs and alignment is adjusted 
and tested until the blade slices evenly across the specimen. The samples were collected with 
frosted slides (Thermo Scientific, USA) and labelled. Slices were collected from the edge and 
centre of the tumours. The slides were then stored in a freezer at -20*C and the sample was 
stored in -80*C.  
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2.7 Cell culture: 
EGFP and wild type human neuroblastoma SK-N-AS cells (ECACC No. 94092302) were cultured 
in Gibco Minimum Essential Medium (MEM) + 10%FCS + 1% NEAA. The GFP labelled cells were 
used for all in vivo experiments and the unlabelled (wild type) cells were used for in-vitro NMR 
experiments. The GFP labelling permits visualisation of the implanted SK-N-AS cells under 
fluorescent light.  
Cells were cultured either in small T25, medium T75, or large T175 flasks depending on the 
output experiment. For cell culture and splitting, the volumes of reagents are indicated in 
table 5 below. 
Table 5. Volumes of reagents required per flask size. 
Flask Size 
(Corning, UK) 
Medium 
volume 
0.05% Trypsin 
for 1 min. 
PBS volume 
T25 5 ml. 0.5 ml. 2 ml. 
T75 20 ml. 1 ml. 5 ml. 
T125 40 ml. 2ml. 5 ml. 
 
Cell passaging was carried out once a flask reaches confluence, typically every 2-3 days. The 
media was aspirated and the cells were washed with PBS, which is added with care to avoid 
detaching the cells. The PBS was then aspirated and 0.05% Trypsin EDTA was added for 1 
minute at 37C.  For CAM implantation, the detached cells were suspended in 10ml of fresh 
media in a falcon tube and counted with a Bio-Rad TC20 Automated Cell Counter. The tube 
was then centrifuged for 5 minutes at 1000rpm to form a cell pellet. The media was then 
aspirated and the pellet was pipetted into an Eppendorf tube and placed on ice. Cell flasks 
were stored in a humidified CO2 incubator (37°C, 5% CO2, Sanyo MC0175). 
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2.7.1 Cell Collection and Freezing prior to Lipid Extraction for NMR: 
SK-N-AS Cells were cultured in small T25 Corning flasks with an initial seeding at 1.00*10^6  
cells in 5ml of media (MEM + 10% (v/v) FCS + 1% (v/v) NEAA) at either 21% O2 (normoxia) or 
1% O2 (hypoxia) for 72h. The cells were harvested and counted as outlined in the cell culture 
methods above. They were then centrifuged in aliquots at 1000rpm for 5 minutes and the 
supernatant was aspirated. The pellet would be resuspended with 1 ml. PBS and the 
suspension transferred into an eppendorf tube which was centrifuged at 1200G for 5 minutes.  
The supernatant was aspirated and the remaining pellet was labelled, snap-frozen with liquid 
nitrogen, and stored in a -80°C freezer until extraction. 
2.7.2 Calculating cell number:  
Once the cells are trypsinised and neutralised with 10 ml of media, 10 μl of media is pipetted 
into a cell counter slide (BioRad, USA) and inserted into the cell counter (Bio-rad TC20, USA) 
with the parameters set between 5 and 23 micrometres. The reading is given as cells/ml. and 
is multiplied according to the appropriate volume. 
2.7.3 Hypoxic Incubation: 
Flasks were incubated in a hypoxic gas chamber (Don Whitley Scientific, 37.1*C, 1.0% O2, 5.0% 
CO2, 94.0% N2) for 72 hours prior to implantation onto the Choriallantoic membrane on 
embryonic day 7 or pellet freezing in the case of cell pellet collection for metabolomics 
analysis. 
2.8 Immunofluorescence and Imaging: 
Slides were thawed at room temperature for 10-20 minutes and a hydrophobic pen 
(Invitrogen, USA) was used to draw a circle around the tissue on the slides. Samples were then 
incubated with 50 mM NH4Cl for 20 minutes at room temperature, followed by 30 minutes of 
incubation in blocking buffer at room temperature (1% (w/v) BSA, 0.1% (v/v) Triton, 0.4% (v/v) 
Tween20 in PBS). After the blocking step, 200μl of the primary antibody (dissolved in blocking 
solution) was added per sample and incubated in a humid chamber overnight at 4°C. 
Upon antibody incubation, the slides underwent three 10 minute cycles of washing with 
blocking solution. The secondary antibody dissolved in blocking solution was then added to 
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the samples (200μl per sample) for 1 hour at room temperature (Table 6). This was followed 
by 2 cycles of rinsing for 10 minutes with PBS. Antibody concentrations used upon 
optimisation are SMA 1:1000 and Antirabbit Alexafluor 555 1:2000 (table 6, supplementary 
fig.3). 
Hoechst nuclear staining dye (1:1000) was added to the samples for 10 minutes maximum 
(200ul. per sample). A 5-minute wash with PBS was followed by an instant wash. The slides 
were dipped into distilled water, dried carefully with blue roll, and subsequently mounted 
with anti-fade mounting medium (DAKO, USA) and coverslips and then stored in the 
refrigerator for at least 1 hour before imaging. 
An Epifluorescent microscope equipped with an Andor iXon Ultra 897 camera was utilised for 
slide imaging (Supplementary fig.3). Table 6 below outlines the antibody dilutions used and 
the microscope settings. 
Table 6: Optimised antibody concentrations used for tumour slices staining 
Primary antibody: SMA 1:1000  
Secondary antibody: Antirabbit Alexafluor 555 1:2000 
Microscope settings: Fluorescent bulb intensity: 6 bars 
Exposure time (ms):  
GFP: 800 
DAPI: 150 
DSRED: 800 
DIC: 10 
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2.9 Metabolomic Analysis: 
2.9.1 Acetyl-Nitrile H2O (AcN-H2O) Tumour extraction: 
Tumours for metabolomic analysis were snap frozen in eppendorf tubes immediately 
following tumour imaging and extraction from the chorioallantoic membrane and stored in a 
-80°C freezer (Sanyo Ultra Low Freezer, Japan).  
The tubes were kept on ice during the acetyl-nitrile extraction. 1.2ml of ice cold AcN-H2O was 
added to each sample followed by three 30 second alternating on-off cycles of sonication 
(MSE UK Soniprep 150 Plus Ultrasonic Disintegrator, amplitude set to 10 kHz using a microtip 
probe). Each sample was subsequently divided into 3 tubes to create technical replicates and 
centrifuged for 5 minutes at 21,500G and 4°C to remove cell debris. The supernatant was then 
transferred into new tubes whilst avoiding aspiration of the pellet. The centrifugation step 
was repeated with the same settings followed by a final transfer of the supernatant into new 
eppendorf tubes. The tubes were snap-frozen in liquid nitrogen and the lids are pierced 
before placing the samples in a lyophiliser (Thermo-Scientific, USA) for dry freezing overnight. 
Samples were stored in a -80°C freezer pending preparation for NMR. 
2.9.2 Acetyl-Nitrile H2O (AcN-H2O) Cell pellet extraction: 
400μl of ice cold AcN-H2O were added to the samples. The samples were not transferred into 
new tubes following sonication, as for tumour samples, because the cells were already 
prepared in triplicates during cell culture. They were transferred after the centrifugation step. 
The remaining steps and settings were identical to the tumour extraction protocol outlined 
above. 
2.9.3 Sample Preparation: 
200 µl of a solution comprising of: 89.8% 2H2O, 10% (v/v) 1mM sodium phosphate (pH 7.4), 
0.1% (v/v) 100mM selectively deuterated (d4) trimethyl silyl propionate (TSP), and 0.1% (v/v) 
1.2mM sodium azide, was added per sample. Samples were vortexed for 1 minute followed 
by 2 minutes of centrifugation (20 oC, 12,000G). The supernatant was pipetted into 3mm NMR 
tubes and arranged in an NMR tube rack. 
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2.9.4 NMR Acquisition: 
1D 
1
H NMR spectra were acquired on a Bruker Avance III HD 700MHz spectrometer equipped 
with a 5mm TCI cryoprobe at pH 7.4 and 25 oC. Two 1D 1H standard metabolomics 
experiments with optimal water suppression were acquired per sample; both are available in 
the Bruker pulse sequence library, the noesypr1d is based on the Nuclear Overhauser Effect 
(NOE) and the cpmgpr1d filters for small molecules via a Carr-Purcell-Meiboom-Gill (CPMG) 
sequence. The noesypr1d was acquired with 32 transients 20ppm spectral width, 32K points, 
10ms mixing time and a 2.73 s acquisition time. The cpmgpr1d was acquired with 256 
transients a 15ppm spectral width, 32K points, 9.6ms echo time and a 3.1 s acquisition time. 
Both spectra were acquired with a 4s interscan delay, the protein-free baseline of the 
cpmgpr1d resulted in these spectra used for downstream analysis. 
2.9.5 Spectral Processing: 
Automated data processing, Fourier transformation, and phasing were carried out in Topspin 
v3.2 software using standard Bruker routines. Chenomx v8.2 software used for initial 
metabolite identification with manual confirmation to in-house standards for metabolite 
peaks found to be significantly variable. The spectra were then normalised to TSP reference 
signal and bucketed per peak into a matrix of metabolite peak intensities using AMIX v3.9.14. 
Statistical analysis was carried out using R (r-project.org) both standalone and via the 
metabolomics server Metaboanalyst v3.0 (89). 
2.10 Statistical Analysis: 
2.10.1 Principal Component Analysis (PCA) and Discriminant Analysis of 
Principal Components (DAPC): 
In order to illustrate the statistical variability between the metabolomic profiles of 
neuroblastoma cells and tumours, principal component analysis (PCA) is utilised. PCA is a 
mathematical method that reduces a large amount of variables, metabolites in this case, into 
smaller sets called principal components. The first principal component will identify the 
largest percentage of variability between the cohorts, with the subsequent principal 
components accounting for the remaining variability in descending order until 100% of the 
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variability has been accounted for. It is a method of illustrating variance via data compression 
and dimensional reduction without discrimination. 
Discriminant analysis of principal components (DAPC) is a statistical method introduced by 
Jobart et al. (2008) as a multivariate analytical tool in biological studies to illustrate 
differences amongst clusters, or cohorts, with minimal intra-cohort variation  (90). In contrast 
to PCA, DAPC is a discriminant tool with prior “knowledge” of the various cohorts.  
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3. Results 
3.1 Hypoxic Preconditioning of cells does not significantly affect 
oxygen tension of tumours: 
In order to investigate the effect of preconditioning SK-N-AS neuroblastoma cells for 3 days 
in a hypoxic environment (1% O2) on the tumour oxygenation, we performed precise live 
oxygen tension readings in tumours. The tumours were formed by cells cultured in either a 
normoxic (21% O2) or hypoxic (1% O2) environment. The use of a model system was essential 
as the collection of similar data in human tumours is complicated by technical and ethical 
challenges as neuroblastoma is a childhood malignancy. Subjecting ill infants to additional 
invasive investigations would place an unnecessary burden and stress on patients and parents 
in addition to resource and cost limitations.  
3.1.1 Differences in Tumour Oxygenation: 
In order to illustrate the test to test variability of oxygenation between the two conditions, 
fig.10 (A-B) displays the mean oxygen tension of each tumour as a function of their 
preconditioning condition and colour coded by experimental repeats. 75% (n=43) of all 
tumours yielded a mean oxygen tension within the range of 0-1% O2 and 25% (n=14) were in 
the range of 1-3% O2. The highest mean oxygen tension recorded was 2.74% in a tumour 
originating from cells preconditioned in hypoxia followed by 2.44% in a tumour from the 
normoxic cells.  
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Mean 
O2 
3d in 21% O2 
(n=24) 
3d in 1% O2 
(n=33) 
<0.2% 0 8 (24%) 
0.2 – 
1% 18 (75%) 17 (52%) 
1 – 3 % 6 (25%) 8 (24%) 
>3 % 0 0 
 
 
Figure 10: Mean Oxygen Tension Measurements. Using a fibre-optic oxygen measurement probe, 
intratumoural O2 tension readings were measured during 11-57 minutes. The O2 levels plotted are the mean 
levels measured during the recording.  
A. Mean oxygen tension of 24 tumours from normoxic cells, colour coded by experiment to allow sample 
matching with B.  
B. Mean oxygen tension of 33 hypoxic tumours. Measurements were performed over 15 batches of eggs. In 2 
replicates, measurements were only obtained from one condition and could not be matched (light blue and 
purple).  
C. The bar graph displays the overall mean oxygen tension ± S.E.M (0.15 in the normoxic set & 0.01 in the 
hypoxic set) of the normoxic and hypoxic tumours calculated as a mean of mean measurements in each sample 
type.  
D. A table illustrating the distribution of the number of tumours into 4 different oxygenation categories. 
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The mean oxygen tension was slightly higher, yet statistically non-significant (p-value= 0.20), 
in tumours originating from cells cultured in normoxia with a mean tension of 0.9% (SD = 0.69) 
versus 0.7% (SD = 0.56) in tumours from cells preconditioned in hypoxia (fig.10 C). Hence, cell 
preconditioning in a hypoxic environment did not produce a significant subsequent effect on 
the oxygenation of the tumour. Moreover, both cell culture conditions generated tumours 
with an overall hypoxic oxygenation status.   
3.1.2 Oxygen Fluctuation is not affected by hypoxic preconditioning: 
To determine whether cell preconditioning affected the cycling of oxygen in tumours, the 
fluctuation ranges were analysed in each tumour (fig.11 A). Fluctuation ranges have been 
classified into three categories determined by the range of oxygen fluctuation in each tumour 
as follows: low (<1%), intermediate (1-3%), and high (>3%) (fig.11 B). A sample trace of a 
tumour oxygen reading over time is displayed in fig.7. 
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O2  Fluctuation 
Range 3d in 21% O2 (n=24) 3d in 1% O2 (n=33) 
Low (<1%) 15 (62.5%) 20 (60.6%) 
Intermediate 
(1-3%) 8 (33.3% 12 (36.4%) 
High (>3%) 1 (4.2%) 1 (3%) 
 
Figure 11. Intratumoural Oxygen Fluctuation. 
A. The boxplots display the range of oxygen tension in tumours during the measurement period. 
Each plot represents a single tumour and is colour coded depending on the condition of the 
implanted cells, red for normoxic cell preconditioning and blue for hypoxic cell preconditioning. The 
mean oxygen tension of each tumour is represented by a horizontal line within each boxplot. The 
range of oxygen tension reached per tumour is identified by the highest and lowest points in each 
plot. N= 24 tumours from the normoxic set and 33 from the hypoxic set. 
B. A table illustrating the oxygen fluctuation of tumours in both sets as divided into three categories 
depending on the range of oxygenation per tumour. 
 
Despite a slight variation, the amount of fluctuation between the two sets of tumours was 
consistent with 62.5% and 60.6% of tumours fluctuating less than 1% in normoxic and hypoxic 
tumours, respectively. Furthermore, the mean fluctuation range is 0.95% O2 in tumours from 
Tumours from cells cultured 3d in 21%O2  N=24  
Tumours from cells cultured 3d in 1% O2    N=33 
A 
B 
Individual tumour fluctuation 
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cells preconditioned in normoxia and 1.03% O2 in tumours from cells preconditioned in 
hypoxia. 
3.1.3 Fluctuation does not increase with longer measurements: 
 
Figure 12. Oxygen Fluctuation depending on measurement time. Red and blue bars 
represent the mean fluctuation ranges of normoxic and hypoxic tumours, respectively. 
Error bars indicate the standard deviation. There is no notable difference in fluctuation over 
time with a 0.1% increase in range in the longer measurements within the same condition. 
Overall fluctuation of all the normoxic and hypoxic tumours are 0.95% and 1.0% ranges, 
respectively. 
 
As hypoxic cycling can be either an acute or chronic state in tumours, we investigated whether 
the differences in measurement durations would under-represent cycling patterns in shorter 
measurements. The range of fluctuation in both tumour sets was less for measurements 
shorter than 33 minutes by 0.7% and 0.13% in the normoxic and hypoxic sets, respectively, 
compared to tumours measured for a longer period (fig.12).  Hence, while the intratumoural 
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oxygen status changes over time, the range of change remains similar if measured for up to 
an hour.  
3.2 Metabolomic analysis of cell and tumour samples 
3.2.1 Principal Component Analysis 
To further establish the intracellular modifications triggered by hypoxic preconditioning we 
analysed the metabolic signature of neuroblastoma cells and neuroblastoma tumours formed 
on the CAM by normoxic or hypoxic preconditioned cells. NMR spectroscopy was used to 
identify the metabolic shift induced by hypoxia. All data are available on EBI 
(http://www.ebi.ac.uk/metabolights/MTBLS541). The spectra were divided into 354 peaks, 
or multiplets, of which 263 were assigned to a total of 98 metabolites. Data transformation 
using Principal Component Analysis (PCA) exhibited variance between the four groups of 
spectra with cells or tumours cultured under hypoxic conditions more varied than those under 
normoxic conditions (fig.13 A). As expected, the metabolic profile of cells cultured in-vitro, 
was different and well separated from cells forming tumours on the CAM in-vivo. Analysis of 
the loadings of metabolites that are most influential in the first and second principal 
components indicate that trehalose, glutathione and mannose together with several 
unidentified metabolites contribute greatest to the variance between spectra (fig.13 B). The 
chemical shifts of the unknown components are consistent with saccharides (whose anomeric 
1H shifts are observed between 4 and 6ppm) or molecules containing aromatic rings (shifts 
observed between 6 and 10 ppm). 
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Figure 13 PCA of cell and tumour metabolite extracts. 
 A. scores plot shows greater variance in spectra of hypoxic samples (cells in black and tumours in 
blue) compared to samples cultured under normoxic conditions (cells in red and tumours in green).  
B. Most influential buckets from PC1 and PC2 (combined). 
C. A sample from the metabolomic analysis spectra generated by Chenomx (v8.2). A spectrum is 
generated for each biological sample with peaks correlating to specific metabolites. Metabolites are 
identified by the software library and subsequently confirmed manually. ppm = parts per million. 
C 
B  
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3.2.2 Discriminant analysis of Principal components (DAPC) 
Discriminant analysis of Principal components (DAPC) was carried out to identify peaks, and 
therefore metabolites, responsible for spectral changes between the hypoxic and normoxic 
cell and tumour models (fig.14). DAPC analysis required just one linear discriminant in order 
to distinguish between hypoxia and normoxia in both cell and tumour models. A comparison 
of the top 10% signals responsible for the separation lead to the identification of metabolites 
that are at different abundances between normoxic and hypoxic conditions in either one or 
both cell and tumour systems. Taurine, choline, lactate, myoinositol, n-acetylcysteine and 
acetonitrile appear in both models. Creatine, glutamate, uridine, n-acetyl-ornithine, and 
aspartate appear in the 10% most influential buckets of the cellular DAPC model only (fig.14 
B) Whereas tyrosine, 2-hydroxybutyrate, 3-hydroxybutyrate, ATP, malonate, and glutathione 
appear in the top 10% of the tumour DAPC model only (fig.14 D). 
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Figure 14 DAPC plots of total NMR metabolite profiles from cells (A, B) and tumours (C, D) 
under hypoxic and normoxic conditions. Linear discriminant 1 for A) hypoxic and normoxic 
cells shown in black and red respectively and C) hypoxic and normoxic tumours shown in blue 
and green respectively. Most influential buckets for the DAPC models for cells (B) and 
tumours (D). 
 
DAPC analysis of the four conditions in one model exhibited greater differences between 
hypoxic and normoxic tumour profiles than between hypoxic and normoxic cell profiles (fig. 
15). With the two-condition model presented in figure 14, we identified taurine, choline, 
lactate, myoinositol, n-acetylcysteine and acetonitrile as being influential in normoxia-
hypoxia group separation.  
C A
 
B
 
D
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Figure 15. DAPC plots of total NMR metabolite profiles from both cells and tumours under hypoxic 
and normoxic conditions. 
A. Scores plot for Linear discriminant 1 and 2 for hypoxic cells (black), normoxic cells (red), 
hypoxic tumours (blue) and normoxic tumours (green).  
B. Most influential buckets for the DAPC model LD1and LD2 combined. 
 
B
 
A
 
The Effects of Hypoxic Preconditioning on the Oxygenation and Metabolic Profile of 
Neuroblastoma – Yousef Al-Mutawa 
 
45 
 
3.2.3 Discriminant Analysis of specific metabolites to distinguish Hypoxia 
from Normoxia 
In order to elucidate the key metabolites in the separation of hypoxic and normoxic tumours 
or cells, a comparison of the most influential buckets for discriminant analysis was made. 
From the DAPC loadings twenty-two metabolites were identified for cells and twenty-one 
metabolites identified for tumours with only nine of the metabolites common to both 
systems. This shortlist of thirty-four metabolite buckets is shown in table 7, with many 
exhibiting P values consistent with significantly different metabolite levels between cells or 
tumour conditions.  
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Table 7. Fold-Change Heatmap for thirty-four identified metabolite peaks that are used to distinguish 
normoxic from hypoxic conditions in cells, tumours or in both models. Strikethroughs indicative of 
metabolite levels not significantly different (P values adjusted for multiple testing by Benjamini-
Hochberg method).  
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The shortlisted metabolites were then used exclusively to perform a Partial Least Squares 
Discriminant Analysis (PLS-DA) between hypoxic and normoxic conditions for either cells or 
tumours. The PLS-DA models for both cells and tumours were optimally fit with 5 components 
(cells) and 8 components (tumours) and yielded well defined separation between hypoxic and 
normoxic conditions with R2 and Q2 of 0.99 and 0.97, respectively, for the cellular model and 
0.99 and 0.96, respectively, for the tumour model (fig.16). Greater variation in the metabolite 
profile of tumour samples (as observed in fig.13) may account for the slightly lower predictive 
Q2 score. 
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Figure 16: PLS-DA models using shortlist of metabolites for either cells (A, B) and tumours 
(C, D) under hypoxic (red or green) and normoxic (black or blue) conditions. Variable 
Influencing Permutation (VIP) scores (B and D) rank the influence of the metabolites over the 
model (for all components). 
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3.2.3.1 Contrasting metabolite regulation between neuroblastoma cells and 
tumours formed on the CAM:  
The most intriguing aspect of our findings are shown in the fold-change heatmap of the 34 
identified metabolite peaks (Table 7). Most metabolite levels between hypoxic and normoxic 
conditions for the discriminating molecules exhibit differing trends between the cellular and 
tumour conditions (fig.17).  
Of the thirty-four metabolite buckets inspected, the majority (n=10) exhibit lower levels 
under hypoxic conditions: lactulose, sucrose, fructose, acetonitrile, glucose, DMSO, malonate, 
cystathione, and citrate.  
Seven metabolites are significantly higher under normoxic conditions in only cells 
(hypoxanthine, guanosine and UMP) or tumours (glutathione, tyrosine, ATP and acetate). 
Three metabolites (inosine, ADP, and uridine) are elevated in normoxic cells in comparison to 
hypoxic cells and are conversely elevated in hypoxic tumours when compared to normoxic 
tumours. 
Five metabolites (3-hydroxybutyrate, lactate, GTP, taurine, and creatinine) are elevated in 
normoxic tumours compared to hypoxic tumours whereas, conversely, are elevated in 
hypoxic cells when compared to normoxic cells. In both cell and tumour extracts, four 
metabolites (isoleucine, 2-hydroxyvalerate, 2-hydroxybutyrate, and glutamate) are at 
significantly higher levels under hypoxic conditions. Myoinositol and choline are not 
significantly altered in either tumour or cell system however multivariate analysis has 
identified them as discriminant between hypoxic and normoxic conditions. This is evinced by 
the high VIP attributed to each in PLS-DA models, highlighting the importance of subtle 
distinctions not identified by crude univariate analysis. 
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These metabolites can be divided into 5 categories:  
- Metabolites that are more abundant in the normoxic sets of both cells and 
tumours in comparison to the hypoxic sets:  
Lactulose, sucrose, fructose, acetonitrile, glucose, DMSO, malonate, 
cystathionine, and citrate. 
- More abundant in normoxic cells vs. hypoxic cells, however, less abundant in 
normoxic tumours vs. hypoxic tumours: 
o ADP, inosine, uridine. 
- Less abundant in normoxic cells, yet more abundant in normoxic tumours: 
o 3-hydroxybutyrate, lactate, GTP, taurine, and creatinine. 
- More abundant in the hypoxic sets of both cells and tumours: 
o Isoleucine, 2-hydroxyvalerate, 2-hydroxybutyrate, and glutamate. 
- Metabolites that are significantly different only within one set: 
o Only within cells: hypoxanthine, guanosine, UMP 
o Only within tumours: GSSG, tyrosine, ATP, acetate, n-acetylcysteine, 
and n-acetylornithine. 
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Figure 17. Boxplots of representative metabolite peaks listed in table 1 for normoxic SK-N-AS Cells 
(CN), hypoxic SK-N-AS cells (CH), tumours from normoxic cells (TN) and tumours from hypoxic cells (TH). 
Bars represent significantly difference between groups (Tukeys post-hoc analysis, adjusted P-value 
<0.05). Dots represent individual samples.   
Colour Coding: Black = Hypoxic Cells, Red = Normoxic Cells, Blue = Tumours from hypoxic cells,            
Green = Tumours from normoxic cells. 
 
4. Discussion: 
This study aimed to quantify and characterise the oxygen tension and oxygenation patterns 
of neuroblastoma tumours developed on the chorioallantoic membrane of the chick embryo 
and subsequently discover the metabolomic profiles of those tumours by utilising NMR 
spectroscopy and specialised analytical software, R, Chenomx, and Metaboanalyst. This was 
an ambitious task, as to our knowledge there is no data on live in vivo oxygen measurements 
of neuroblastoma tumours. Moreover, metabolomics is a relatively new field amongst the –
omic sciences (genomics, transcriptomics, and proteomics) and the advanced multivariate 
statistics and analytical techniques necessary to translate complex, heterogeneous chemical 
data into presentable results and visual representations require innovative proficiency. 
The oxygen measurements and metabolomic profiling of neuroblastoma tumours are 
complementary investigations that allow us to identify the physiological and metabolic 
aspects of a neuroblastoma tumour in response to hypoxic preconditioning, instead of 
investigating an isolated outcome.  
4.1 Tumour Oxygenation: 
4.1.1 The Effect of Hypoxic Preconditioning: 
The preconditioning of neuroblastoma SK-N-AS cells in a hypoxic environment for three days 
did not result in a significantly lower mean oxygen tension than that of the tumours that 
originated from SK-N-AS cells preconditioned in normoxia. Despite an absence of a significant 
difference (p-value = 0.2; 0.9% vs 0.69% mean pO2 of the normoxic and hypoxic sets, 
respectively), the long-lasting effects of the hypoxic preconditioning are evident in the 
metastatic activation of tumours as shown by Herrmann et al. (2015) and by the changes in 
the metabolic profiles of the tumours and cells (84). The majority of tumours from both sets 
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had a mean oxygen tension ranging from 0.2-1% O2 (fig.10). It is noteworthy that no tumour 
from both sets has a mean oxygen tension of >3%, signifying that tumour cells exhibit a mild 
hypoxic microenvironment and that although hypoxic preconditioning will alter a tumour’s 
metastatic behaviour it will not significantly impact the tumour’s oxygen tension. In 
comparison, the median oxygen tensions of tumours as reported in the literature are as 
follows: Glioblastoma (0.79%), Head and neck carcinoma (1.7-2%), prostate cancer (0.34%), 
lung (1.05%), cervical cancer (0.42-0.71%), and pancreatic cancer (0.38%) (64). 
4.1.2 Oxygen Fluctuation: 
By the late 1980s, several measurement techniques such as NMR spectroscopy and 
polarographic electrodes were being utilised for tumour oxygen measurements with variable 
rates of sensitivity and success (91). Of relevance, Chaplin et al. (1986) observed that tumour 
hypoxia can transpire as chronic, diffusion-limited hypoxia or acute, transient hypoxia (92). 
This phenomenon of dynamic and heterogeneous tumour hypoxia has been further evaluated 
and confirmed by ensuing research (79, 93).  
Hence, it was necessary to investigate whether longer tumour oxygen measurements would 
highlight notable differences in the cycling of hypoxia and whether we would detect higher 
ranges of fluctuation within a tumour with longer readings. Our in vivo oxygen tension 
recordings of neuroblastoma tumours confirm the dynamic state of tumour oxygenation in 
both tumour sets (fig.11 A). However, hypoxic preconditioning of tumour cells did not seem 
to exaggerate or decrease the range of fluctuation (fig.11 B). Our fluctuation results reflect 
the findings of Brurberg et al. (2005) which did not show any correlation between oxygen 
fluctuation and oxygenation status of canine tumours (94). 
Together, these data confirm that oxygen levels in neuroblastoma are fluctuating and that 
the metastatic phenotype, acquired by hypoxic preconditioning, results in a slightly lower 
overall mean of oxygen levels without influencing the occurrence of cycling hypoxia. The 
spatial and temporal heterogeneity of our neuroblastoma tumour oxygen measurements are 
consistent with the characteristics of tumour oxygen measurements in the literature (64, 77, 
79, 95, 96).  
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4.1.3 Limitations of oxygen measurements: 
The limitations with respect to gathering tumour measurement recordings were represented 
by the variability in tumour sizes which posed technical challenges in placing the fibre-optic 
sensor via the micromanipulator precisely within the tumour without causing tumour 
haemorrhage or tissue damage. Chick movements during the recording period may result in 
artefact fluctuations by slightly changing the needle’s position. Additionally, time was a 
limiting factor and it was not practical to gather longer oxygen readings with the number of 
tumours to be recorded in each experimental setup.  
4.2 Metabolomics: 
4.2.1 Principal component analysis (PCA) 
Principal component analysis (PCA) was utilised to illustrate the variance between the four 
experimental conditions (cells and tumours divided into either normoxic or hypoxic 
preconditioning). Interestingly, greater variance was shown between oxygenation conditions 
rather than the biological systems. Both the cells and tumours from the normoxic set 
clustered more closely than the cells and tumours of the hypoxic set. This may signify the 
underlying metabolic disruptive effects of hypoxia on both an in vitro and in vivo level. 
Trehalose, the most influential metabolite from Principal components (PC) 1 and 2 combined, 
is a disaccharide known for its resistance to acidic conditions (fig.13 B) (97). Glutathione, a 
metabolite formed from cysteine, functions as a cellular antioxidant defense mechanism and 
as an enzymatic coenzyme and has been directly linked to carcinogenesis and 
chemoresistance (98, 99). Increased glutathione levels have been found to contribute to the 
resistance to oxidative stress characteristic of tumour cells (99). The third most influential 
identified metabolite in PC1 and 2 is mannose, a carbohydrate molecule (fig.13 B). 
Furthermore, boxplot representation (fig.18) reveals mannose to be more abundant in 
hypoxic cells and tumours than their normoxic counterparts. This correlates with the findings 
of Kotze (2012) which showed decreased mannose in normoxic tumour cells in comparison 
to hypoxic preconditioned cells (100). Recently, mannose receptors have been identified as 
transport proteins on tumour-associated macrophages (TAM) and are being utilised in 
cytotoxic drug delivery and in vivo tumour imaging  (101-103).  
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Figure 18. A boxplot representation illustrating the contrasting abundance of mannose in both 
cells and tumours. Colour Coding: Black = Hypoxic Cells, Red = Normoxic Cells, Blue = Tumours from 
hypoxic cells, Green = Tumours from normoxic cells. 
 
While PCA showed greater variance between hypoxic and normoxic conditions rather than 
between cells and tumours, discriminant analysis revealed a greater variance between 
hypoxic and normoxic tumour sets than between cells. 
4.2.2 Heatmap: 
Our results showed increased levels of lactate in the hypoxic cells in comparison to the 
normoxic cells which is an expected finding in line with the Warburg Hypothesis of aerobic 
glycolysis (42, 49). However, in tumours, we detected higher levels of lactate within the 
tumours originating from normoxic cells. Although, it is noteworthy to recall that unlike the 
cells, all of the tumours exhibited a hypoxic microenvironment regardless of hypoxic 
preconditioning of the cells as illustrated by our oxygen measurements (fig.10). 
Although more detectable in cells than in tumours, there was no significant difference in myo-
inositol levels amongst both sets. However, myo-inositol was found to be decreased in 
response to tumour hypoxia in breast cancer and increased in neuroblastoma biopsies (58, 
104).  
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In contrast to the findings of Tsai et al. (2013), glutamate levels were increased in the hypoxic 
sets of both cells and tumours (104). Higher glutamate levels in response to hypoxia were also 
detected in human glioblastoma cells and in Stage I-II neuroblastoma biopsies (58, 105).  
Taurine and choline are amongst the metabolites responsible for spectral separation in both 
cells and tumours (fig.14). Interestingly, NMR spectroscopy of neuroblastoma samples 
detected increased levels of taurine in patients with a poor prognosis (58). Additionally, 
increased concentrations of taurine and choline have been detected in colon cancer and in 
response to hypoxia in human glioblastoma cells (105, 106). Our results showed higher levels 
of taurine in hypoxic SK-N-AS cells than in normoxic cells. Conversely, the pattern is reversed 
in tumours, with higher taurine levels in tumours originating from cells cultured in normoxia. 
Moreover, there was no significant difference in the levels of choline between the normoxic 
and hypoxic cells and tumours. However, choline was more abundant in tumours than in cells.  
It is likely that DMSO and acetonitrile are products of the culture media and extraction lysate, 
respectively. Multiple carbohydrates, citrate, and ATP are also lower under hypoxic 
conditions, consistent with productive glycolysis and the citric acid cycle in normoxic 
conditions when compared to oxygen deprived environments. Lower nucleotide levels 
(inosine, ADP, and uridine) in hypoxic cells may suggest reduced protein production and 
biosynthesis in comparison to cells cultured in a normoxic condition. Isoleucine, 2-
hydroxyvalerate, and 2-hydroxybutyrate were found to be significantly higher in the hypoxic 
sets of both cells and tumours. These metabolites have been associated with lactic acidosis 
and associated metabolic diseases (107-109). Interestingly, hydroxybutyrate, a ketone body, 
has been associated with the acceleration of tumour growth and tumour inhibition in what 
has been termed as the ‘butyrate paradox’ (110, 111). Unsurprisingly, the majority of 
metabolites are detected at higher levels in tumours than in cells irrespective of oxygen levels 
with notable exceptions being media components glutamate, creatinine, and ATP. 
Moreover, various notable metabolites not identified in our findings have shown a significant 
reaction to tumour hypoxia in the literature of which some are: glutamine, phenylalanine, 
valine, leucine, methionine, pyruvate, formate, creatine, alanine, creatine phosphate, and 
proline (58, 104, 105). Additionally, a recent meta-analysis of clinical metabolomic studies 
encompassing 18 types of cancer confirmed the finding of increased glycolysis and highlighted 
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metabolites previously less associated with cancer such as histidine and tryptophan, both of 
which have not been detected in our data (112).  
Whilst the cellular experiments reflected the expected metabolic changes in accordance to 
the Warburg Effect with higher levels of lactate in the hypoxic sets, it becomes more complex 
to ascertain in our tumour analysis (49, 112). Firstly, the cell is an isolated system whereas 
the tumour samples are heterogeneous in size and contents of tissue, stroma, and 
vasculature. Additionally, the hypoxic effects are more pronounced in the cellular 
experiments as the comparison was made between normoxic and hypoxic cells. Moreover, 
our experiments have shown that while the effects of hypoxic preconditioning of the cells 
persisted in the phenotype and metabolic profiles of the tumours, the oxygenation of the 
tumours was not effected and both tumour sets had hypoxic microenvironments.  
Although, from a clinical perspective, tumour samples derived from different hosts are 
heterogeneous with varying microenvironments, it was necessary to eliminate any 
confounding variables in preparing and analysing the in-vivo samples by following 
standardised extraction procedures. Developing rigorous protocols is a necessity in NMR 
research as metabolomic analysis is easily affected by sample preparation and host variation 
(56). The advantages of our approach to tumour metabolomics analysis lie in the number of 
tumours extracted, stored, and analysed in a standardised environment and protocol. The 
standardised, controlled, and high throughput advantage gained from the chick embryo 
model provides efficient replication with limited sample degradation and avoids the drawback 
of running metabolomic analysis on aged clinical tumour samples stored for years (113). 
Additionally, our protocol divides each tumour into a triplicate during extraction to test 
reproducibility, identify sample differences, and validate our findings. 
Understandably, the majority of studies focus on metabolite profiling of biofluids such as 
serum and urine as these samples are easily obtainable and do not involve invasive or surgical 
procedures as would be the case in tumour biopsies. This study provides insight on the 
metabolic profile directly from the epicenter of the disease rather than the biofluids produced 
secondary to it.  
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5. Conclusion: 
Manipulation of oxygen levels in a preclinical model has shown that in addition to altering the 
phenotype of SKNAS cells by inciting aggressive metastasis, certain metabolic shifts are 
evident in in-vitro and in-vivo models as a result of hypoxic preconditioning. The crucial 
knowledge gained from the oxygen readings is that the distinction between normoxia and 
hypoxia is not reflected in tumour oxygenation and that the measured neuroblastoma 
tumours are essentially hypoxic environments regardless of cell preconditioning. Hence, the 
comparison of metabolite intensities in tumours is effectively between the tumour history 
and the status of the cells used to form them. 
The implications of these findings are the enduring biological effects triggered by hypoxia on 
cancer cells even prior to tumourigenesis. To our knowledge, this is the first study to 
investigate the differences in the metabolomic response to hypoxic preconditioning in cells in 
vitro and in vivo tumours.  
The new aspects provided in this study supplement previous work by Hermann et al. (2015) 
on the direct link between cellular hypoxia and tumour metastasis and extend the concept of 
cellular memory of hypoxia into metabolite activity (84).  
The idea of metabolic alteration as a hallmark in cancer biology dates back to Otto Warburg’s 
discovery in the early 20th century of altered lactate production in cancer. Continuous 
research efforts are now focussed on metabolomics as the biological discipline that may allow 
the discovery of tumour biomarkers that will aid in early detection and disease stratification 
in cancer. However, the early findings tend to be broad and descriptive before the 
investigatory tools are advanced enough to provide precise answers and solutions.  
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6. Appendix:  
 
Supplementary Figure 2 – Tumour Images in Bright Field & GFP 
CAM         
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Supplementary Figure 3. This figure displays images of the neuroblastoma tumours 
on the CAM and after dissection. They are shown in bright field and GFP views. The 
neuroblastoma SK-N-AS cells used are GFP-labelled and appear in green in GFP view. 
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Supplementary Figure 3: Immunofluorescent Imaging of Tumour 
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Supplementary Figure 4. This figure shows tumour cell intravasation. Tumour sections 
have been stained with various concentrations of primary (SMA) and secondary (Antirabbit 
555) fluorescent antibodies. The GFP-labelled SK-N-AS cells appear in green, cellular nuclei 
appear in blue, and vessels appear in red. 
Antibody concentrations are as detailed below: 
A. SMA 1:1000     555 1:2000 
B. SMA 1:1000     555 1:1000 
C. SMA 1:800       555  1:600 
D. SMA 1:800       555 1:1000 
E. SMA 1:800       555 1:2000 
F. SMA 1:400       555 1:600 
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